Results 201 to 210 of about 35,499 (222)

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.

Antibiotics, 2021
Concepción Gonzalez-Bello, German Bou, Jorge Arca-Suárez   +2 more
exaly  

β-Lactamase inhibitors and Acinetobacter spp.

Journal of Antimicrobial Chemotherapy, 1990
R H, Eng, S M, Smith, C E, Cherubin
openaire   +2 more sources

Biology of Acinetobacter spp.

2020
openaire   +1 more source

Occurrence and Characterization of NDM-1-Producing Shewanella spp. and Acinetobacter portensis Co-Harboring tet(X3) in a Chinese Dairy Farm

Antibiotics, 2022
Zhiqiang Wang, Li Ruichao, Xiaoyu Lu
exaly  

Karbapeneme Dirençli Acinetobacter Spp. İnfeksiyonları

Karbapeneme dirençli Acinetobacter baumannii-calcoaceticus kompleksi (CRAB), özellikle YBÜ’lerde sağlık bakımıyla ilişkili infeksiyonların önde gelen etkenlerinden biri haline gelmiştir. CRAB infeksiyonları YBÜ’de kalış süresi, artan hasta maliyeti, antibiyotik kullanımı ve mortaliteyle anlamlı bir ilişki gösterir.
openaire   +1 more source

Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals

Clinical Microbiology and Infection, 2005
Alexandr Nemec, K J Towner, A T Bernards   +2 more
exaly  

First Identification ofblaOXA-51-likein Non-baumanniiAcinetobacter spp.

Journal of Chemotherapy, 2009
Jane Turton, Yi-Tzu Lee, Chien-Pei Chen   +2 more
exaly  

Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India

Microbiology and Immunology, 2011
Biswajit Maiti, Indrani Karunasagar
exaly  

Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany

Microbial Drug Resistance, 2017
Heime Rieber
exaly  

Nosocomial Pneumonia Caused by Acinetobacter spp.

2020
Jean Chastre, Jean-Louis Trouillet, Albert Vuagnat, Marie-Laure Joly-Guillou   +3 more
openaire   +1 more source